Aljurf, Mahmoud

Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10

Walne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I. (2007) · Human Molecular Genetics

Telomeres, Telomerase, and SenescenceBlood disorders and treatments

Cited by 316

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

Majhail, N. S., Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Bone Marrow Transplantation

Hematopoietic Stem Cell TransplantationCancer survivorship and care

Cited by 248

Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT

Peric, Z., Botti, S., Stringer, J., Krawczyk, J., van der Werf, S., van Biezen, A., Aljurf, M., Murray, J., Liptrott, S., Greenfield, D. M., et al. (2018) · Bone Marrow Transplantation

Clinical Nutrition and GastroenterologyHematopoietic Stem Cell Transplantation

Cited by 54

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT

Chalandon, Y., Sbianchi, G., Gras, L., Koster, L., Apperley, J., Byrne, J., Salmenniemi, U., Sengeloev, H., Aljurf, M., Helbig, G., et al. (2023) · American Journal of Hematology

Chronic Myeloid Leukemia TreatmentsHematopoietic Stem Cell Transplantation

Cited by 24

Chimeric antigen receptor structure and manufacturing of clinical grade CAR engineered cells using different bioreactors

Syed, F., El Fakih, R., Alahmari, A. D., Ali, A. S. O., & Aljurf, M. (2022) · Hematology/Oncology and Stem Cell Therapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 18

Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

Ortí, G., Gras, L., Koster, L., Kulagin, A., Byrne, J., Apperley, J. F., Halaburda, K., Blau, I. W., Clark, A., Kröger, N., et al. (2024) · Transplantation and Cellular Therapy

Hematopoietic Stem Cell TransplantationRenal Transplantation Outcomes and Treatments

Cited by 9